Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Cahill

Showing results (151-160 of 196) with videos related to

Pageof 20
Sort By:
Cancer Cell|December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ DepletionKensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Pigment Cell & Melanoma Research|August 1, 2022
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunitiesAlcida Karz, Maya Dimitrova, Kevin Kleffman, et al.
Cancer Discovery|September 27, 2018
Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in <i>KRAS</i>-Mutant Non-Small Cell Lung CancerVaruna Nangia, Faria M Siddiqui, Sean Caenepeel, et al.
Neuro-Oncology|October 25, 2025
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect groupNico Teske, Antonio Dono, Jacob S Young, et al.
Blood|March 18, 2021
A rapid genotyping panel for detection of primary central nervous system lymphomaMihir Gupta, Evan J Burns, Nicholas Z Georgantas, et al.
Cancer Cell|April 5, 2024
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendrogliomaAvishay Spitzer, Simon Gritsch, Masashi Nomura, et al.
Neuro-Oncology|May 29, 2025
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4Aleksandra B Lasica, Zhou Lan, Julie J Miller, et al.
Cancer Research|October 17, 2020
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System LymphomaKensuke Tateishi, Yohei Miyake, Masahito Kawazu, et al.
Nature Communications|October 13, 2021
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Cell|September 18, 2018
Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in GliomaSamuel K McBrayer, Jared R Mayers, Gabriel J DiNatale, et al.
Pageof 20

Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
Cancer Cell|December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ DepletionKensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Pigment Cell & Melanoma Research|August 1, 2022
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunitiesAlcida Karz, Maya Dimitrova, Kevin Kleffman, et al.
Cancer Discovery|September 27, 2018
Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in <i>KRAS</i>-Mutant Non-Small Cell Lung CancerVaruna Nangia, Faria M Siddiqui, Sean Caenepeel, et al.
Neuro-Oncology|October 25, 2025
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect groupNico Teske, Antonio Dono, Jacob S Young, et al.
Blood|March 18, 2021
A rapid genotyping panel for detection of primary central nervous system lymphomaMihir Gupta, Evan J Burns, Nicholas Z Georgantas, et al.
Cancer Cell|April 5, 2024
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendrogliomaAvishay Spitzer, Simon Gritsch, Masashi Nomura, et al.
Neuro-Oncology|May 29, 2025
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4Aleksandra B Lasica, Zhou Lan, Julie J Miller, et al.
Cancer Research|October 17, 2020
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System LymphomaKensuke Tateishi, Yohei Miyake, Masahito Kawazu, et al.
Nature Communications|October 13, 2021
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Cell|September 18, 2018
Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in GliomaSamuel K McBrayer, Jared R Mayers, Gabriel J DiNatale, et al.
Pageof 20